CIHR Operating Grant: Evaluation of Harm Reduction Approaches to Address the Opioid Crisis in the Context of COVID-19

Maximum Value


Sponsor Deadline

November 12, 2021

UBCO RPIF Deadline

November 9, 2021 at 12:00 pm

NOI/LOI Deadline


UBCO E-submission Deadline


Program Description

The intersection of COVID-19 and substance use represents the confluence of two severe public health crises, with the COVID-19 pandemic compounding the ongoing opioid crisis. There is a clear increased risk of harm to people who use drugs or who have a substance use disorder in the COVID-19 context due to self-isolation requirements, physical distancing measures, and/or an increasingly toxic illegal drug supply. CIHR is launching this evaluation-focused funding opportunity to address harm reduction approaches to the opioid crisis and to better understand its compounding intersection with the COVID-19 pandemic.

Full Program Terms

Proposal Development Support

For support in preparing a UBCO-led application, please get in touch with the contact below:

Stacey Leavitt

How to Apply

Last updated: 2022-12-09 12:00

Comments are closed, but trackbacks and pingbacks are open.